Neurocrine Biosciences, Inc. company logo
Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc. (NBIX) Cash From Financing

Annual CFF

-$486.70M$552.00M-845.33%

Summary

Current Value
As of today, NBIX annual cash from financing is -$486.70M, down -845.33% on
Historical Performance
NBIX annual cash from financing is down -1876.28% over the past 3 years, and down -1602.16% over the past 5 years
All-Time High Comparison
NBIX annual cash from financing is currently -194.20% below its historical high of $516.65M set on
3-Year Low Comparison
NBIX annual cash from financing is at its 3-year low
Sector Comparison
NBIX annual cash from financing is higher than 5.85% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NBIX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$486.70M-845.3%-1876.3%-1602.2%-5016.2%
Quarterly Cash From Financing$45.60M+72.7%+300.0%+1724.0%+10000.0%
TTM Cash From Financing-$365.60M-126.7%-42.2%-1365.8%-1268.7%
Price$140.62+2.2%+14.3%+36.8%+1777.4%
Annual Cash From Operations$595.40M+52.7%+132.1%+305.0%+1221.4%
Annual Cash From Investing-$126.80M+72.8%+2.6%+39.9%-1151.7%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$495.70M+7.7%+8.5%-1.6%+100.0%
Shares Outstanding99.71M+0.3%+3.3%+6.6%

Cash From Financing Highs

NBIX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$65.30M-845.3%
5Y$65.30M-845.3%
All$516.65M-194.2%

Cash From Financing Lows

NBIX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$486.70Mat low
5Y-$486.70Mat low
All-$486.70Mat low

Cash From Financing History

YearValueChange
-$486.70M-845.3%
$65.30M+127.9%
-$234.30M-955.1%
$27.40M+117.4%
-$157.80M-587.0%
$32.40M+9.8%
YearValueChange
$29.50M-94.3%
$516.65M>+9,900.0%
$2.39M-99.1%
$276.99M+99.7%
$138.73M-

FAQ

  • What is the current annual cash from financing of NBIX?

    As of today, NBIX annual cash from financing is -$486.70M

  • What is 1-year change in NBIX annual cash from financing?

    NBIX annual cash from financing is down -845.33% year-over-year

  • What is 3-year change in NBIX annual cash from financing?

    NBIX annual cash from financing is down -1876.28% over the past 3 years

  • How far is NBIX annual cash from financing from its all-time high?

    NBIX annual cash from financing is currently -194.20% below its historical high of $516.65M set on December 31, 2017

  • How does NBIX annual cash from financing rank versus sector peers?

    NBIX annual cash from financing is higher than 5.85% of companies in Healthcare sector

  • When is NBIX next annual earnings release?

    The next annual earnings release for NBIX is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. NBIX Official Website www.neurocrine.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
  4. NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
  5. NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix